Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 289

1.

Circulating cell free (ccf) DNA testing: are some test failures informative?

Palomaki G, Kloza E, Lambert-Messerlian G, van den Boom D, Ehrich M, Deciu C, Bombard A, Haddow J.

Prenat Diagn. 2014 Dec 2. doi: 10.1002/pd.4541. [Epub ahead of print]

PMID:
25449554
[PubMed - as supplied by publisher]
2.

Implications of High Free Thyroxine (FT4) concentrations in euthyroid pregnancies: the FaSTER trial.

Haddow JE, Craig WY, Neveux LM, Haddow HR, Palomaki GE, Lambert-Messerlian G, Malone FD, D'Alton ME; First and Second Trimester Risk of Aneuploidy (FaSTER) Research Consortium.

J Clin Endocrinol Metab. 2014 Jun;99(6):2038-44. doi: 10.1210/jc.2014-1053. Epub 2014 Feb 28.

PMID:
24606107
[PubMed - indexed for MEDLINE]
3.

The EGAPP initiative: lessons learned.

Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group.

Genet Med. 2014 Mar;16(3):217-24. doi: 10.1038/gim.2013.110. Epub 2013 Aug 8. Review.

PMID:
23928914
[PubMed - indexed for MEDLINE]
4.

Screening for down syndrome in the United States: results of surveys in 2011 and 2012.

Palomaki GE, Knight GJ, Ashwood ER, Best RG, Haddow JE.

Arch Pathol Lab Med. 2013 Jul;137(7):921-6. doi: 10.5858/arpa.2012-0319-CP.

PMID:
23808464
[PubMed - indexed for MEDLINE]
5.

The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidies.

Canick JA, Palomaki GE, Kloza EM, Lambert-Messerlian GM, Haddow JE.

Prenat Diagn. 2013 Jul;33(7):667-74. doi: 10.1002/pd.4126. Epub 2013 May 31.

PMID:
23592541
[PubMed - indexed for MEDLINE]
6.

Maternal thyroxine and fetal brain development: the latest chapter, a look back, and considerations for the future.

Haddow JE.

J Clin Endocrinol Metab. 2013 Apr;98(4):1388-90. doi: 10.1210/jc.2013-1646. No abstract available.

PMID:
23564943
[PubMed - indexed for MEDLINE]
7.

Recommendations from the EGAPP Working Group: can testing of tumor tissue for mutations in EGFR pathway downstream effector genes in patients with metastatic colorectal cancer improve health outcomes by guiding decisions regarding anti-EGFR therapy?

Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group.

Genet Med. 2013 Jul;15(7):517-27. doi: 10.1038/gim.2012.184. Epub 2013 Feb 21.

PMID:
23429431
[PubMed - indexed for MEDLINE]
8.

Impact of adjusting for the reciprocal relationship between maternal weight and free thyroxine during early pregnancy.

Haddow JE, Craig WY, Palomaki GE, Neveux LM, Lambert-Messerlian G, Canick JA, Malone FD, D'Alton ME; First And Second Trimester Risk Of Aneuploidy Faster Research Consortium.

Thyroid. 2013 Feb;23(2):225-30. doi: 10.1089/thy.2012.0440.

PMID:
23136959
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Improving the efficiency and relevance of evidence-based recommendations in the era of whole-genome sequencing: an EGAPP methods update.

Veenstra DL, Piper M, Haddow JE, Pauker SG, Klein R, Richards CS, Tunis SR, Djulbegovic B, Marrone M, Lin JS, Berg AO, Calonge N.

Genet Med. 2013 Jan;15(1):14-24. doi: 10.1038/gim.2012.106. Epub 2012 Sep 6. Review.

PMID:
22955111
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

DNA sequencing of maternal plasma to identify Down syndrome and other trisomies in multiple gestations.

Canick JA, Kloza EM, Lambert-Messerlian GM, Haddow JE, Ehrich M, van den Boom D, Bombard AT, Deciu C, Palomaki GE.

Prenat Diagn. 2012 Aug;32(8):730-4. doi: 10.1002/pd.3892. Epub 2012 May 14.

PMID:
22585317
[PubMed - indexed for MEDLINE]
11.

DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study.

Palomaki GE, Deciu C, Kloza EM, Lambert-Messerlian GM, Haddow JE, Neveux LM, Ehrich M, van den Boom D, Bombard AT, Grody WW, Nelson SF, Canick JA.

Genet Med. 2012 Mar;14(3):296-305. doi: 10.1038/gim.2011.73. Epub 2012 Feb 2.

PMID:
22281937
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

The Canadian recommendations on screening for type 2 diabetes.

Wald NJ, Haddow JE.

J Med Screen. 2012 Dec;19(4):163. doi: 10.1177/0969141313476677. No abstract available.

PMID:
23486696
[PubMed - indexed for MEDLINE]
13.

Screening to detect Lynch syndrome and prevent hereditary cancers in relatives.

Haddow JE, Palomaki GE.

J Med Screen. 2011;18(4):167-8. doi: 10.1258/jms.2011.011139. No abstract available.

PMID:
22184732
[PubMed - indexed for MEDLINE]
14.

Mid-gestational maternal free thyroxine concentration and offspring neurocognitive development at age two years.

Craig WY, Allan WC, Kloza EM, Pulkkinen AJ, Waisbren S, Spratt DI, Palomaki GE, Neveux LM, Haddow JE.

J Clin Endocrinol Metab. 2012 Jan;97(1):E22-8. doi: 10.1210/jc.2011-1772. Epub 2011 Oct 26.

PMID:
22031521
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study.

Palomaki GE, Kloza EM, Lambert-Messerlian GM, Haddow JE, Neveux LM, Ehrich M, van den Boom D, Bombard AT, Deciu C, Grody WW, Nelson SF, Canick JA.

Genet Med. 2011 Nov;13(11):913-20. doi: 10.1097/GIM.0b013e3182368a0e.

PMID:
22005709
[PubMed - indexed for MEDLINE]
16.

The new American Thyroid Association Guidelines for thyroid disease during pregnancy and postpartum: a blueprint for improving prenatal care.

Haddow JE.

Thyroid. 2011 Oct;21(10):1047-8. doi: 10.1089/thy.2011.2110.ed1. No abstract available.

PMID:
21943133
[PubMed - indexed for MEDLINE]
17.

Folic acid and neural tube defects.

Haddow JE.

Genet Med. 2011 Sep;13(9):849; author reply 849. doi: 10.1097/GIM.0b013e3182326e9d. No abstract available.

PMID:
21885925
[PubMed - indexed for MEDLINE]
18.

Vitamin D and rickets: much has been accomplished, but there is room for improvement.

Haddow JE.

J Med Screen. 2011;18(2):58-9. doi: 10.1258/jms.2011.011059. No abstract available.

PMID:
21852696
[PubMed - indexed for MEDLINE]
19.

The relationship between PTH and 25-hydroxy vitamin D early in pregnancy.

Haddow JE, Neveux LM, Palomaki GE, Lambert-Messerlian G, Canick JA, Grenache DG, Lu J.

Clin Endocrinol (Oxf). 2011 Sep;75(3):309-14. doi: 10.1111/j.1365-2265.2011.04066.x.

PMID:
21521334
[PubMed - indexed for MEDLINE]
20.

Further insights into implications of undetectable or very low unconjugated estriol in maternal serum during the second trimester.

Craig WY, Palomaki G, Roberson M, Haddow JE.

Prenat Diagn. 2011 Jun;31(6):616-8. doi: 10.1002/pd.2754. Epub 2011 Apr 7. No abstract available.

PMID:
21472738
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk